STOCK TITAN

[FWP] Citigroup Inc. Free Writing Prospectus

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
FWP
Rhea-AI Filing Summary

On 06/25/2025, President & COO (and 10% owner) Nathan Eric Baxter filed a Form 4 reporting the acquisition of 93.7383 common shares of The Scotts Miracle-Gro Company (SMG) at $53.34 per share (transaction code J). After the purchase, his direct holdings total 50,602.6841 shares, while 36,993 shares remain held indirectly through Hagedorn Partnership, L.P. No derivative security activity was disclosed, and the filing does not amend any prior report. The transaction increases Baxter’s direct stake by roughly 0.19%, an immaterial amount relative to his overall ownership and SMG’s share count, indicating a routine adjustment rather than a strategic accumulation. Nevertheless, the buy modestly reinforces executive-shareholder alignment because it adds to an already significant insider position.

Il 25/06/2025, il Presidente e COO (nonché proprietario del 10%) Nathan Eric Baxter ha presentato un Modulo 4 segnalando l'acquisto di 93,7383 azioni ordinarie della The Scotts Miracle-Gro Company (SMG) al prezzo di 53,34 $ per azione (codice transazione J). Dopo l'acquisto, il suo possesso diretto ammonta a 50.602,6841 azioni, mentre 36.993 azioni restano detenute indirettamente tramite Hagedorn Partnership, L.P. Non sono state comunicate attività su strumenti derivati e la dichiarazione non modifica alcun rapporto precedente. L'operazione aumenta la quota diretta di Baxter di circa il 0,19%, una quantità irrilevante rispetto alla sua proprietà complessiva e al numero di azioni SMG, indicando un aggiustamento di routine piuttosto che un accumulo strategico. Tuttavia, l'acquisto rafforza modestamente l'allineamento tra dirigente e azionista, poiché si aggiunge a una posizione interna già significativa.

El 25/06/2025, el Presidente y COO (y propietario del 10%) Nathan Eric Baxter presentó un Formulario 4 reportando la adquisición de 93,7383 acciones ordinarias de The Scotts Miracle-Gro Company (SMG) a 53,34 $ por acción (código de transacción J). Tras la compra, sus tenencias directas suman 50.602,6841 acciones, mientras que 36.993 acciones permanecen en posesión indirecta a través de Hagedorn Partnership, L.P. No se divulgó actividad con valores derivados y la presentación no modifica ningún informe previo. La transacción incrementa la participación directa de Baxter en aproximadamente un 0,19%, una cantidad insignificante en relación con su propiedad total y el número de acciones de SMG, lo que indica un ajuste rutinario más que una acumulación estratégica. No obstante, la compra refuerza modestamente la alineación entre ejecutivo y accionista, al añadir a una posición interna ya significativa.

2025년 6월 25일, 회장 겸 COO(10% 지분 보유자) Nathan Eric Baxter가 Form 4를 제출하여 The Scotts Miracle-Gro Company(SMG)의 보통주 93.7383주를 주당 53.34달러에 취득했다고 보고했습니다(거래 코드 J). 매수 후 그의 직접 보유 주식은 총 50,602.6841주이며, 36,993주는 Hagedorn Partnership, L.P.를 통해 간접적으로 보유 중입니다. 파생상품 거래 내역은 공개되지 않았으며, 이번 제출은 이전 보고서를 수정하지 않습니다. 이번 거래로 Baxter의 직접 지분은 약 0.19% 증가했으며, 이는 전체 소유 지분 및 SMG 주식 수에 비해 미미한 수치로 전략적 축적보다는 일상적인 조정임을 나타냅니다. 그럼에도 불구하고 이번 매수는 이미 상당한 내부자 지분에 더해 경영진과 주주 간의 연계를 다소 강화합니다.

Le 25/06/2025, le Président et COO (et détenteur de 10%) Nathan Eric Baxter a déposé un formulaire 4 signalant l'acquisition de 93,7383 actions ordinaires de The Scotts Miracle-Gro Company (SMG) au prix de 53,34 $ par action (code transaction J). Après cet achat, ses avoirs directs s'élèvent à 50 602,6841 actions, tandis que 36 993 actions restent détenues indirectement via Hagedorn Partnership, L.P. Aucune activité sur titres dérivés n'a été divulguée, et le dépôt ne modifie aucun rapport antérieur. Cette transaction augmente la participation directe de Baxter d'environ 0,19%, une somme négligeable par rapport à sa détention globale et au nombre d'actions de SMG, indiquant un ajustement de routine plutôt qu'une accumulation stratégique. Néanmoins, cet achat renforce modestement l'alignement entre dirigeant et actionnaire, car il s'ajoute à une position d'initié déjà significative.

Am 25.06.2025 reichte Präsident und COO (sowie 10% Eigentümer) Nathan Eric Baxter ein Formular 4 ein, in dem der Erwerb von 93,7383 Stammaktien der The Scotts Miracle-Gro Company (SMG) zu einem Preis von 53,34 $ pro Aktie gemeldet wurde (Transaktionscode J). Nach dem Kauf beläuft sich sein direkter Bestand auf insgesamt 50.602,6841 Aktien, während 36.993 Aktien weiterhin indirekt über die Hagedorn Partnership, L.P. gehalten werden. Es wurden keine Aktivitäten mit derivativen Wertpapieren offengelegt, und die Meldung ändert keinen früheren Bericht. Die Transaktion erhöht Baxters direkten Anteil um etwa 0,19%, was im Verhältnis zu seinem Gesamtbesitz und der Aktienanzahl von SMG unerheblich ist und eher eine routinemäßige Anpassung als eine strategische Aufstockung darstellt. Dennoch stärkt der Kauf die Ausrichtung zwischen Führungskraft und Aktionär leicht, da er eine bereits bedeutende Insiderposition erweitert.

Positive
  • Insider alignment: President & COO Nathan Baxter added 93.74 shares, lifting direct ownership to 50,602.68 shares.
Negative
  • Immaterial size: The purchase amounts to less than 0.2% of Baxter’s existing stake, offering limited insight into future performance.

Insights

TL;DR — Minor insider buy; neutral market impact, slight positive governance signal.

The 93.7-share purchase by President & COO Nathan Baxter is economically negligible (<1% of his stake, de minimis versus float) and coded J, suggesting a non-open-market adjustment. With no derivative activity and no change in indirect holdings, the filing is informational rather than materially market-moving. Investors may view any insider acquisition as a confidence cue, but the tiny size limits signaling power, keeping the overall impact neutral.

Il 25/06/2025, il Presidente e COO (nonché proprietario del 10%) Nathan Eric Baxter ha presentato un Modulo 4 segnalando l'acquisto di 93,7383 azioni ordinarie della The Scotts Miracle-Gro Company (SMG) al prezzo di 53,34 $ per azione (codice transazione J). Dopo l'acquisto, il suo possesso diretto ammonta a 50.602,6841 azioni, mentre 36.993 azioni restano detenute indirettamente tramite Hagedorn Partnership, L.P. Non sono state comunicate attività su strumenti derivati e la dichiarazione non modifica alcun rapporto precedente. L'operazione aumenta la quota diretta di Baxter di circa il 0,19%, una quantità irrilevante rispetto alla sua proprietà complessiva e al numero di azioni SMG, indicando un aggiustamento di routine piuttosto che un accumulo strategico. Tuttavia, l'acquisto rafforza modestamente l'allineamento tra dirigente e azionista, poiché si aggiunge a una posizione interna già significativa.

El 25/06/2025, el Presidente y COO (y propietario del 10%) Nathan Eric Baxter presentó un Formulario 4 reportando la adquisición de 93,7383 acciones ordinarias de The Scotts Miracle-Gro Company (SMG) a 53,34 $ por acción (código de transacción J). Tras la compra, sus tenencias directas suman 50.602,6841 acciones, mientras que 36.993 acciones permanecen en posesión indirecta a través de Hagedorn Partnership, L.P. No se divulgó actividad con valores derivados y la presentación no modifica ningún informe previo. La transacción incrementa la participación directa de Baxter en aproximadamente un 0,19%, una cantidad insignificante en relación con su propiedad total y el número de acciones de SMG, lo que indica un ajuste rutinario más que una acumulación estratégica. No obstante, la compra refuerza modestamente la alineación entre ejecutivo y accionista, al añadir a una posición interna ya significativa.

2025년 6월 25일, 회장 겸 COO(10% 지분 보유자) Nathan Eric Baxter가 Form 4를 제출하여 The Scotts Miracle-Gro Company(SMG)의 보통주 93.7383주를 주당 53.34달러에 취득했다고 보고했습니다(거래 코드 J). 매수 후 그의 직접 보유 주식은 총 50,602.6841주이며, 36,993주는 Hagedorn Partnership, L.P.를 통해 간접적으로 보유 중입니다. 파생상품 거래 내역은 공개되지 않았으며, 이번 제출은 이전 보고서를 수정하지 않습니다. 이번 거래로 Baxter의 직접 지분은 약 0.19% 증가했으며, 이는 전체 소유 지분 및 SMG 주식 수에 비해 미미한 수치로 전략적 축적보다는 일상적인 조정임을 나타냅니다. 그럼에도 불구하고 이번 매수는 이미 상당한 내부자 지분에 더해 경영진과 주주 간의 연계를 다소 강화합니다.

Le 25/06/2025, le Président et COO (et détenteur de 10%) Nathan Eric Baxter a déposé un formulaire 4 signalant l'acquisition de 93,7383 actions ordinaires de The Scotts Miracle-Gro Company (SMG) au prix de 53,34 $ par action (code transaction J). Après cet achat, ses avoirs directs s'élèvent à 50 602,6841 actions, tandis que 36 993 actions restent détenues indirectement via Hagedorn Partnership, L.P. Aucune activité sur titres dérivés n'a été divulguée, et le dépôt ne modifie aucun rapport antérieur. Cette transaction augmente la participation directe de Baxter d'environ 0,19%, une somme négligeable par rapport à sa détention globale et au nombre d'actions de SMG, indiquant un ajustement de routine plutôt qu'une accumulation stratégique. Néanmoins, cet achat renforce modestement l'alignement entre dirigeant et actionnaire, car il s'ajoute à une position d'initié déjà significative.

Am 25.06.2025 reichte Präsident und COO (sowie 10% Eigentümer) Nathan Eric Baxter ein Formular 4 ein, in dem der Erwerb von 93,7383 Stammaktien der The Scotts Miracle-Gro Company (SMG) zu einem Preis von 53,34 $ pro Aktie gemeldet wurde (Transaktionscode J). Nach dem Kauf beläuft sich sein direkter Bestand auf insgesamt 50.602,6841 Aktien, während 36.993 Aktien weiterhin indirekt über die Hagedorn Partnership, L.P. gehalten werden. Es wurden keine Aktivitäten mit derivativen Wertpapieren offengelegt, und die Meldung ändert keinen früheren Bericht. Die Transaktion erhöht Baxters direkten Anteil um etwa 0,19%, was im Verhältnis zu seinem Gesamtbesitz und der Aktienanzahl von SMG unerheblich ist und eher eine routinemäßige Anpassung als eine strategische Aufstockung darstellt. Dennoch stärkt der Kauf die Ausrichtung zwischen Führungskraft und Aktionär leicht, da er eine bereits bedeutende Insiderposition erweitert.

Citigroup Global Markets Holdings Inc.

&nbsp;

Free Writing Prospectus to Pricing Supplement No. 2025-USNCH27493

Registration Statement Nos. 333-270327; 333-270327-01

Dated July 7, 2025; Filed pursuant to Rule 433

Contingent Income Auto-Callable Securities Due July , 2028 Based on the Performance of the Common Stock of NVIDIA Corporation

Principal at Risk Securities

This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, prospectus supplement and prospectus, and the &ldquo;Risk Considerations&rdquo; on the following page, prior to making an investment decision.

Summary Terms
Issuer: Citigroup Global Markets Holdings Inc.
Guarantor: Citigroup Inc.
Underlying shares: NVIDIA Corporation (ticker symbol: &ldquo;NVDA UW&rdquo;)
Stated principal amount: $1,000 per security
Pricing date: July 18, 2025
Issue date: July 23, 2025
Valuation dates, potential redemption dates and contingent coupon payment dates:

The expected valuation dates, potential redemption dates and contingent coupon payment dates are set forth below:

Valuation dates* Potential redemption dates* Contingent coupon payment dates**
October 20, 2025 October 20, 2025 October 23, 2025
January 20, 2026 January 20, 2026 January 23, 2026
April 20, 2026 April 20, 2026 April 23, 2026
July 20, 2026 July 20, 2026 July 23, 2026
October 19, 2026 October 19, 2026 October 22, 2026
January 19, 2027 January 19, 2027 January 22, 2027
&nbsp; April 19, 2027 April 19, 2027 April 22, 2027
&nbsp; July 19, 2027 July 19, 2027 July 22, 2027
&nbsp; October 18, 2027 October 18, 2027 October 21, 2027
&nbsp; January 18, 2028 January 18, 2028 January 21, 2028
&nbsp; April 18, 2028 April 18, 2028 April 21, 2028
&nbsp; July 18, 2028 (the &ldquo;final valuation date&rdquo;) N/A July 21, 2028 (the &ldquo;maturity date&rdquo;)
&nbsp;

* Each valuation date is subject to postponement if such date is not a scheduled trading day or certain market disruption events occur, as described in the accompanying product supplement. Each potential redemption date is subject to postponement on the same basis as a valuation date.

** If the valuation date immediately preceding any contingent coupon payment date (other than the final valuation date) is postponed, that contingent coupon payment date will also be postponed so that it falls on the third business day after such valuation date, as postponed.

Maturity date: Unless earlier automatically redeemed, July 21, 2028
Contingent coupon: On each quarterly contingent coupon payment date, unless previously automatically redeemed, the securities will pay a contingent coupon equal to at least 3.075% of the stated principal amount of the securities (at least 12.30% per annum) (to be determined on the pricing date) if and only if the closing price of the underlying shares on the related valuation date is greater than or equal to the downside threshold price. If the closing price of the underlying shares on any quarterly valuation date is less than the downside threshold price, you will not receive any contingent coupon payment on the related contingent coupon payment date. If the closing price of the underlying shares is less than the downside threshold price on one or more valuation dates and, on a subsequent valuation date, the closing price of the underlying shares is greater than or equal to the downside threshold price, your contingent coupon payment for that subsequent valuation date will include all previously unpaid quarterly contingent coupon payments (without interest on amounts previously unpaid). However, if the closing price of the underlying shares is less than the downside threshold price on any valuation date and on each subsequent valuation date thereafter, you will not receive the unpaid contingent coupon payments in respect of those valuation dates.
Payment at maturity1:

If the securities are not automatically redeemed prior to maturity, for each $1,000 stated principal amount security you hold at maturity, you will receive cash in an amount determined as follows:

&middot; &nbsp;&nbsp;&nbsp;&nbsp;If the final share price is greater than or equal to the downside threshold price: $1,000 + the contingent coupon payment due at maturity (including any previously unpaid quarterly contingent coupon payments)

&middot; &nbsp;&nbsp;&nbsp;&nbsp;If the final share price is less than the downside threshold price:&nbsp;

$1,000 + ($1,000 &times; the share return)

If the final share price is less than the downside threshold price, you will receive less, and possibly significantly less, than 60.00% of the stated principal amount of your securities at maturity, and you will not receive any contingent coupon payment at maturity.

Automatic early redemption: If, on any potential redemption date, the closing price of the underlying shares on that date is greater than or equal to the initial share price, each security you then hold will be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to the early redemption payment. If the securities are redeemed, no further payments will be made.
Early redemption payment: The stated principal amount of $1,000 per security plus the related contingent coupon payment (including any previously unpaid quarterly contingent coupon payments)
Initial share price: The closing price of the underlying shares on the pricing date
Final share price: The closing price of the underlying shares on the final valuation date
Downside threshold price: 60.00% of the initial share price
Share return: (i) The final share price minus the initial share price, divided by (ii) the initial share price
CUSIP / ISIN: 17333LHN8 / US17333LHN82
Preliminary pricing supplement: Preliminary pricing supplement dated July 7, 2025

&nbsp;

Hypothetical Payout at Maturity1

(if the securities have not been previously redeemed)

Share Return of Underlying Shares on the Final Valuation Date Payment at Maturity (excluding any coupon payable at maturity)
+40.00% $1,000.00
+30.00% $1,000.00
+20.00% $1,000.00
+10.00% $1,000.00
0.00% $1,000.00
-10.00% $1,000.00
-20.00% $1,000.00
-30.00% $1,000.00
-40.00% $1,000.00
-41.00% $590.00
-50.00% $500.00
-60.00% $400.00
-70.00% $300.00
-80.00% $200.00
-90.00% $100.00
-100.00% $0.00

1 All payments are subject to our credit risk

&nbsp;

On the date of the accompanying preliminary pricing supplement, Citigroup Global Markets Holdings Inc. expects that the estimated value of the securities on the pricing date will be at least $921.00 per security, which will be less than the public offering price. The estimated value of the securities is based on Citigroup Global Markets Inc.&rsquo;s (&ldquo;CGMI&rdquo;) proprietary pricing models and Citigroup Global Markets Holdings Inc.&rsquo;s internal funding rate. It is not an indication of actual profit to CGMI or other of Citigroup Global Markets Holdings Inc.&rsquo;s affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time after issuance. See &ldquo;Valuation of the Securities&rdquo; in the accompanying preliminary pricing supplement.

&nbsp;

&nbsp;

&nbsp;

Citigroup Global Markets Holdings Inc. and Citigroup Inc. have filed registration statements (including the accompanying preliminary pricing supplement, product supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) for the offering to which this communication relates. Before you invest, you should read the accompanying preliminary pricing supplement, product supplement, prospectus supplement and prospectus in those registration statements (File Nos. 333-270327 and 333-270327-01) and the other documents Citigroup Global Markets Holdings Inc. and Citigroup Inc. have filed with the SEC for more complete information about Citigroup Global Markets Holdings Inc., Citigroup Inc. and this offering. You may obtain these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, you can request these documents by calling toll-free 1-800-831-9146.

Underlying Shares

For more information about the underlying shares, including historical performance information, see the accompanying preliminary pricing supplement.

Risk Considerations

The risks set forth below are discussed in more detail in the &ldquo;Summary Risk Factors&rdquo; section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.

&middot;You may lose a significant portion or all of your investment.
&middot;You will not receive any contingent coupon payment for any quarter in which the closing price of the underlying shares is less than the downside threshold price on the related valuation date.
&middot;Higher contingent coupon rates are associated with greater risk.
&middot;You may not be adequately compensated for assuming the downside risk of the underlying shares.
&middot;The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.
&middot;The securities offer downside exposure to the underlying shares, but no upside exposure to the underlying shares.
&middot;The performance of the securities will depend on the closing price of the underlying shares solely on the relevant valuation dates, which makes the securities particularly sensitive to the volatility of the underlying shares.
&middot;The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.
&middot;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.
&middot;The estimated value of the securities on the pricing date, based on Citigroup Global Markets Inc.&rsquo;s proprietary pricing models and Citigroup Global Markets Holdings Inc.&rsquo;s internal funding rate, will be less than the issue price.
&middot;The estimated value of the securities would be lower if it were calculated based on Citigroup Global Markets Holdings Inc.&rsquo;s secondary market rate.
&middot;The estimated value of the securities is not an indication of the price, if any, at which Citigroup Global Markets Inc. or any other person may be willing to buy the securities from you in the secondary market.
&middot;The value of the securities prior to maturity will fluctuate based on many unpredictable factors.
&middot;Immediately following issuance, any secondary market bid price provided by Citigroup Global Markets Inc., and the value that will be indicated on any brokerage account statements prepared by Citigroup Global Markets Inc. or its affiliates, will reflect a temporary upward adjustment.
&middot;Governmental regulatory actions, such as sanctions, could adversely affect your investment in the securities.
&middot;Citigroup Global Markets Holdings Inc.&rsquo;s offering of the securities does not constitute a recommendation of any underlying shares.
&middot;The price of the underlying shares may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.
&middot;Citigroup Global Markets Holdings Inc. and its affiliates may have economic interests that are adverse to yours as a result of the business activities of Citigroup Global Markets Holdings Inc.&rsquo;s affiliates.
&middot;You will have no rights and will not receive dividends with respect to the underlying shares.
&middot;Even if the underlying share issuer pays a dividend that it identifies as special or extraordinary, no adjustment will be required under the securities for that dividend unless it meets the criteria specified in the accompanying product supplement.
&middot;The securities will not be adjusted for all events that could affect the price of the underlying shares.
&middot;If the underlying shares are delisted, we may call the securities prior to maturity for an amount that may be less than the stated principal amount.
&middot;The securities may become linked to shares of an issuer other than the original underlying share issuer upon the occurrence of a reorganization event or upon the delisting of the underlying shares.
&middot;The calculation agent, which is an affiliate of Citigroup Global Markets Holdings Inc., will make important determinations with respect to the securities.
&middot;The U.S. federal tax consequences of an investment in the securities are unclear.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary pricing supplement under the heading &ldquo;United States Federal Tax Considerations&rdquo; concerning the U.S. federal tax consequences of an investment in the securities, and you should consult your tax adviser.

&nbsp;

&nbsp;

&nbsp;

&nbsp;

FAQ

What did SMG insider Nathan Baxter report on his Form 4?

He acquired 93.7383 common shares at $53.34 on 06/25/2025.

How many Scotts Miracle-Gro shares does Baxter own after the transaction?

He now holds 50,602.6841 shares directly and 36,993 shares indirectly through Hagedorn Partnership, L.P.

Were any derivative securities involved in this Form 4 filing for SMG?

No. The filing shows no derivative security transactions for the reporting period.

What transaction code was used and what does it indicate?

The filing lists Code J; in Form 4 this denotes an "other" type of acquisition or disposition not classified under standard codes.

Does this insider purchase significantly change SMG’s ownership structure?

No. The 93.7-share buy is immaterial relative to Baxter’s existing stake and to SMG’s total shares outstanding.
Citigroup Inc

NYSE:C

C Rankings

C Latest News

C Latest SEC Filings

C Stock Data

160.31B
1.83B
1.01%
76.85%
1.81%
Banks - Diversified
National Commercial Banks
Link
United States
NEW YORK